These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6791208)

  • 1. Differential effects of IV and IP muscimol on central dopamine metabolism.
    Gundlach AL; Beart PM
    Psychopharmacology (Berl); 1981; 74(1):71-3. PubMed ID: 6791208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of muscimol on dopamine metabolism of the rat hypothalamus.
    Gundlach AL; Beart PM
    Experientia; 1980 Nov; 36(11):1312-3. PubMed ID: 7449921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscimol-induced increase in dopamine release and metabolism is not observed in kainic acid-lesioned striatum of conscious rats: an in vivo microdialysis study.
    Yoshida M; Mizoguchi K; Yokoo H; Tanaka T; Ishii H; Emoto H; Koga C; Tanaka M
    Neurosci Lett; 1993 Nov; 162(1-2):5-8. PubMed ID: 8121635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local muscimol disinhibits mesolimbic dopaminergic activity as examined by brain microdialysis and Fos immunohistochemistry.
    Yoshida M; Yokoo H; Nakahara K; Tomita M; Hamada N; Ishikawa M; Hatakeyama J; Tanaka M; Nagatsu I
    Brain Res; 1997 Sep; 767(2):356-60. PubMed ID: 9367268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baclofen and muscimol: behavioural and neurochemical sequelae of unilateral intranigral administration and effects on 3H-GABA receptor binding.
    Waddington JL; Cross AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):275-80. PubMed ID: 471079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of typical and atypical neuroleptics on the behavioural consequences of activation by muscimol of mesolimbic and nigro-striatal dopaminergic pathways in the rat.
    Oakley NR; Hayes AG; Sheehan MJ
    Psychopharmacology (Berl); 1991; 105(2):204-8. PubMed ID: 1686655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifications of DOPAC levels in the striatum and olfactory tubercles of the rat after muscimol.
    Restelli A; Zambotti F; Vicentini L; Zonta N; Mantegazza P
    Pharmacol Res Commun; 1979 Jan; 11(1):55-9. PubMed ID: 424439
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of muscimol and baclofen on levels of monoamines and their metabolites in the El mouse brain.
    Kabuto H; Yokoi I; Mori A
    Neurochem Res; 1988 Dec; 13(12):1157-61. PubMed ID: 3237308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the GABA receptor agonist muscimol on the turnover of brain dopamine and on the motor activity of rats.
    Andén NE; Grabowska-Andén M; Wachtel H
    Acta Pharmacol Toxicol (Copenh); 1979 Mar; 44(3):191-6. PubMed ID: 433609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of dopamine in circling responses to muscimol depends on intranigral site of injection.
    Kilpatrick IC; Starr MS
    Eur J Pharmacol; 1981 Feb; 69(4):407-19. PubMed ID: 6265225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-dihydroxyphenylacetic acid (DOPAC) and the rat mesolimbic dopaminergic pathway: drug effects and evidence for somatodendritic mechanisms.
    Beart PM; Gundlach AL
    Br J Pharmacol; 1980 Jun; 69(2):241-7. PubMed ID: 6108139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.
    Koulu M; Lappalainen J; Pesonen U; Hietala J; Syvälahti E
    Eur J Pharmacol; 1988 Oct; 155(3):313-6. PubMed ID: 3069483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleus accumbens dopamine release modulation by mesolimbic GABAA receptors-an in vivo electrochemical study.
    Xi ZX; Stein EA
    Brain Res; 1998 Jul; 798(1-2):156-65. PubMed ID: 9666112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in striatal dopamine activity following nigral muscimol infusions.
    Moshé SL; Sperber EF; Wurpel JN; Sharpless NS
    Brain Res; 1987 Jan; 428(1):129-32. PubMed ID: 3815107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranigral GABAergic drug effects on striatal dopamine activity.
    Sperber EF; Wurpel JN; Sharpless NS; Moshé SL
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1067-70. PubMed ID: 2477863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release.
    Guan XM; McBride WJ
    Brain Res Bull; 1989 Dec; 23(6):541-7. PubMed ID: 2575444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections.
    Vezina P; Blanc G; Glowinski J; Tassin JP
    J Pharmacol Exp Ther; 1992 May; 261(2):484-90. PubMed ID: 1578364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circling behavior induced by intranigral injections of GABA and muscimol in rats.
    Kaakkola S; Kääriäinen I
    Psychopharmacology (Berl); 1980; 68(1):31-6. PubMed ID: 6771796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterization of the properties of a multifiber carbon electrode allowing long-term electrochemical detection of dopamine in freely moving animals.
    el Ganouni S; Forni C; Nieoullon A
    Brain Res; 1987 Feb; 404(1-2):239-56. PubMed ID: 3494483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.